Search - tctmd.com

Displaying 221 - 240 of 332

Sort: Relevancy | Date

News Conference News TCT 2014

COMPARE II: STEMI Patients See Strong Results with Both BES and EES

September 14, 2014

Presentation TCT 2014

TCT 644: Stent Thrombosis Rates of the Biodegradable Polymer, Biolimus-Eluting Stent Versus the Durable Polymer, Everolimus-Eluting Stent in All Comers Undergoing PCI: A Pooled Analysis of the COMPARE II and NEXT Trials at 1 Year

Presenter: Valentin Fuster, Pieter C. Smits

September 13, 2014

News Conference News TCT 2014

COMPARE II: BES, EES Show Similar Outcomes at Three Years

September 13, 2014

News Conference News ESC 2014

PROTECT: ZES Sustain Lead Over SES at 5 Years

Caitlin E. Cox

September 03, 2014

News Daily News

PROTECT: Lower Stent Thrombosis Risk with Endeavor Emerges at 4 Years

L.A. McKeown

September 02, 2014

News Conference News ESC 2014

BIOSCIENCE: Biodegradable Polymer SES Noninferior to Durable Polymer EES in All-Comers Trial

Yael L. Maxwell

September 01, 2014

News Daily News

GARY: Majority of Patients Do Well With TAVR or Surgery at 1 Year

L.A. McKeown

August 20, 2014

Presentation BRS 2014

Is ABSORB ready for an ‘all-comers’ randomized trial? The upcoming COMPARE-ABSORB trial

Presenter: P.C. Smits

July 26, 2014

News Daily News

Bioresorbable Scaffold Performs Well, But Thrombosis Raises Concerns

Todd Neale

July 24, 2014

News Industry News

BIOTRONIK Announces Completion of Enrollment in SFA Arm of the BIOFLEX-I Study

July 22, 2014

News Daily News

HOST-ASSURE: Promus Element Noninferior to Resolute in All-Comers Population

July 10, 2014

News Industry News

BIOTRONIK Announces First Enrollments to BIOFLEX PEACE Registry

July 10, 2014

Presentation

Randomized Comparison of PtCr-EES vs CoCr-ZES in All-Comers Receiving PCI

Presenter: K.W. Park

July 07, 2014

News Daily News

Post-AMI Ischemic Stroke Rates Down, Hemorrhagic Stroke Stable Since 1999

Leah Lawrence

July 03, 2014

News Industry News

PEACE I All Comers Registry Results Demonstrate Efficacy of BIOTRONIK Pulsar-18 Self-Expanding Stent

June 13, 2014

News Daily News

Nobori BES Equals Promus Element in Long Lesions

Jason Kahn

May 30, 2014

News Daily News

El SLF Nobori es Similar al Promus Element en el Manejo de Lesiones Largas

Jason Kahn

May 30, 2014

Presentation EuroPCR 2014

Final Five-year Outcomes from the Randomized Comparison of Zotarolimus-eluting Stents With Everolimus-eluting Stents in the RESOLUTE All Comers Trial

Presenter: Stephan Windecker

May 22, 2014

News Conference News ACC 2014

NEXT at 2 Years: Nobori DES Still Noninferior to Xience/Promus

Jason Kahn

March 31, 2014

Presentation CIT 2014

RESOLUTE China Registry: 1 Year (N = 1800) and 2 Year (N = 830) Outcomes from an All-Comers Chinese Population of Patients Implanted with the Resolute™ Zotarolimus-Eluting Stent

Presenter: Dr. Chen Shaoliang

March 22, 2014

Advertisement

COMPARE II: STEMI Patients See Strong Results with Both BES and EES

TCT 644: Stent Thrombosis Rates of the Biodegradable Polymer, Biolimus-Eluting Stent Versus the Durable Polymer, Everolimus-Eluting Stent in All Comers Undergoing PCI: A Pooled Analysis of the COMPARE II and NEXT Trials at 1 Year

COMPARE II: BES, EES Show Similar Outcomes at Three Years

PROTECT: ZES Sustain Lead Over SES at 5 Years

PROTECT: Lower Stent Thrombosis Risk with Endeavor Emerges at 4 Years

BIOSCIENCE: Biodegradable Polymer SES Noninferior to Durable Polymer EES in All-Comers Trial

GARY: Majority of Patients Do Well With TAVR or Surgery at 1 Year

Is ABSORB ready for an ‘all-comers’ randomized trial? The upcoming COMPARE-ABSORB trial

Bioresorbable Scaffold Performs Well, But Thrombosis Raises Concerns

BIOTRONIK Announces Completion of Enrollment in SFA Arm of the BIOFLEX-I Study

HOST-ASSURE: Promus Element Noninferior to Resolute in All-Comers Population

BIOTRONIK Announces First Enrollments to BIOFLEX PEACE Registry

Randomized Comparison of PtCr-EES vs CoCr-ZES in All-Comers Receiving PCI

Post-AMI Ischemic Stroke Rates Down, Hemorrhagic Stroke Stable Since 1999

PEACE I All Comers Registry Results Demonstrate Efficacy of BIOTRONIK Pulsar-18 Self-Expanding Stent

Nobori BES Equals Promus Element in Long Lesions

El SLF Nobori es Similar al Promus Element en el Manejo de Lesiones Largas

Final Five-year Outcomes from the Randomized Comparison of Zotarolimus-eluting Stents With Everolimus-eluting Stents in the RESOLUTE All Comers Trial

NEXT at 2 Years: Nobori DES Still Noninferior to Xience/Promus

RESOLUTE China Registry: 1 Year (N = 1800) and 2 Year (N = 830) Outcomes from an All-Comers Chinese Population of Patients Implanted with the Resolute™ Zotarolimus-Eluting Stent

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content